SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 72 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,421,000 | +127.9% | 246,302 | +49.8% | 0.02% | +112.5% |
| Q3 2017 | $1,940,000 | +54.0% | 164,412 | +37.0% | 0.01% | +60.0% |
| Q2 2017 | $1,260,000 | +7311.8% | 120,005 | +7815.9% | 0.01% | – |
| Q1 2017 | $17,000 | -19.0% | 1,516 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | +10.5% | 1,516 | 0.0% | 0.00% | – |
| Q3 2016 | $19,000 | +11.8% | 1,516 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | 0.0% | 1,516 | 0.0% | 0.00% | – |
| Q1 2016 | $17,000 | -67.9% | 1,516 | -50.8% | 0.00% | – |
| Q4 2015 | $53,000 | +76.7% | 3,079 | +103.1% | 0.00% | – |
| Q3 2015 | $30,000 | -62.5% | 1,516 | -69.1% | 0.00% | – |
| Q2 2015 | $80,000 | +5.3% | 4,900 | 0.0% | 0.00% | – |
| Q1 2015 | $76,000 | -76.9% | 4,900 | -78.8% | 0.00% | -100.0% |
| Q4 2014 | $329,000 | +683.3% | 23,060 | +258.7% | 0.00% | – |
| Q3 2014 | $42,000 | -34.4% | 6,429 | -30.5% | 0.00% | – |
| Q2 2014 | $64,000 | -3.0% | 9,249 | 0.0% | 0.00% | – |
| Q1 2014 | $66,000 | -24.1% | 9,249 | 0.0% | 0.00% | – |
| Q4 2013 | $87,000 | +50.0% | 9,249 | 0.0% | 0.00% | – |
| Q3 2013 | $58,000 | +132.0% | 9,249 | +145.7% | 0.00% | – |
| Q2 2013 | $25,000 | – | 3,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 311 | $6,000 | 0.00% |
| NOMURA HOLDINGS INC | 33,500 | $599,000 | 0.00% |
| IFP Advisors, Inc | 384 | $7,000 | 0.00% |
| GLENMEDE TRUST CO NA | 461 | $8,000 | 0.00% |